NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Nestlé SA Faces Scrutiny in Infant Nutrition Business

Market Value: $70 billion (global infant nutrition segment)

Company Overview: Nestlé SA, the world's largest food company, is facing fresh challenges in its infant nutrition business, a crucial segment for the company's growth. While India has not been directly impacted by a recent global product recall, reputational concerns could still influence the company's market positioning in one of its most important growth markets.

Key Developments:

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • Controversy over added sugar in emerging markets: An investigation found that Nestlé sold infant products with added sugar in countries, including India, while similar products sold in Europe contained no added sugar.
  • Global product recall linked to contamination: Nestlé recalled infant formula products after detecting cereulide, a toxin associated with Bacillus cereus, in certain batches.

Indian Market Impact:

  • India is a key market for Nestlé's Cerelac business and a major driver for infant nutrition demand.
  • Although India was not directly affected by the recall, the earlier sugar controversy affected the company's reputation and briefly weighed on its share price.
  • Indian regulators have begun reviewing infant food standards, while Nestlé has started rolling out "No Added Sugar" labels in response to consumer concerns.

Global Market Positioning:

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

  • Nestlé remains the market leader in infant nutrition with over 20% share.
  • The segment contributes about 17% of the company's group revenue.

Industry-Wide Scrutiny:

  • Food companies often adapt formulations to local regulations and consumer preferences.
  • Rivals, such as Danone and Reckitt, follow similar practices across markets.
  • Regulators, including the FDA in the United States, are paying closer attention to infant formula safety and supply chain oversight.

Financial Impact:

  • Nestlé recorded a financial impact of about 185 million Swiss Franc from write-offs and returns related to the recall.
  • The company maintains multiple layers of quality checks across its global supply chain and treats product safety as a central priority.

Investor Takeaway

Investors should be cautious of potential reputational damage to Nestlé's infant nutrition business.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.